Product Image

Vitamin D3 + K2

SportsResearch
4.8
★ ★ ★ ★ ★
(25035 ratings)
Vitamin K 100 mcg
Product Image
Score80
Best suited to adults wanting a D3 and MK-7 softgel after verifying the vitamin D dose; duplicate vitamin D entries make it unclear whether the true dose is 125 mcg or twice that amount, so the current package should be checked before use.
How scoring works
Quantity:60 Softgel(s) • (120 servings)
Goals:
Bone Health
Heart Health
General Health
Cardiovascular Support
Anti-Aging

Score 80

Best suited to adults wanting a D3 and MK-7 softgel after verifying the vitamin D dose; duplicate vitamin D entries make it unclear whether the true dose is 125 mcg or twice that amount, so the current package should be checked before use.
How scoring works

Also available as

1 option
100.00mcg • 60 Softgel(s) servings K 100 mcg • 60 Softgel(s) • 60 servings $23.95 ($0.39 per serving)
$44.97($0.37 per serving)
iHerb
$ 44.97
Report prices

Analysis

MK-7 and vitamin D3 in a liquid softgel provide a well-aligned format for bone and calcium-handling support. The label provides enough detail to judge the central vitamin strategy.

Duplicate vitamin D entries make it unclear whether the true dose is 125 mcg or twice that amount, so the current package should be checked before use. Format, dose, and companion nutrients determine whether it is appropriate for daily use.

The best fit is adults wanting a D3 and MK-7 softgel after verifying the vitamin D dose. Vitamin K and vitamin D support normal physiology, but the practical benefit depends on baseline intake and individual need.

Who is it for
  • Adults wanting a D3 and MK-7 softgel after verifying the vitamin D dose
  • Adults whose current vitamin intake matches the listed potency
  • Users able to account for vitamin K medication interactions
Best for
  • Useful 100 mcg MK-7 amount
  • Liquid softgel supports fat-soluble delivery
  • Users who accept that vitamin d appears twice in the supplied data

Pros

  • Useful 100 mcg MK-7 amount
  • Liquid softgel supports fat-soluble delivery
  • Strong bone-health alignment
  • Large serving count

Cons

  • Vitamin D appears twice in the supplied data
  • Potential vitamin D exposure is very high
  • Not a standalone K2 option
  • Dose ambiguity weakens label confidence

Warnings

  • Verify the package because duplicate 125 mcg vitamin D entries could imply a total above the usual adult daily upper limit.
  • The 100 mcg MK-7 serving can counteract warfarin and related vitamin K antagonist anticoagulants.
  • High vitamin D intake may worsen hypercalcemia or some kidney-stone risks, particularly when calcium intake is also high.

Nutrient quality

86 Highest impact

Cholecalciferol and MK-7 are useful forms delivered in a suitable softgel, and the 100 mcg MK-7 amount is meaningful, while the 125 mcg vitamin D3 amount is concentrated. The vitamin D3 amount reaches a concentrated daily level that may be excessive when status is already adequate, while vitamin D3 and K2 form a coherent combination for calcium handling and bone support.

.

Ingredient transparency

72 High impact

Amounts are listed, but duplicate vitamin D entries make the active total ambiguous, and no proprietary blend hides the dose of a listed active ingredient. Serving count is supplied, but complete daily-use directions are not provided, while inactive ingredients and excipients are not included in the supplied label details.

.

Customer satisfaction

76 High impact

The supplied average rating is strong, and extensive review volume makes the average rating more dependable. Specific review themes are unavailable, so repeated negatives and real-world fit remain uncertain.

.

Value for money

86 Highest impact

The ingredient forms and dosing generally justify the product positioning, and the moderate serving cost is reasonable for the disclosed actives. The focused active profile is not inflated by low-value additions, while the formula and serving value compare well with similar products.

.
Report analysis

Goals

Bone Health
Bone Health
Impact
Highest effect
A+ Goal FitA- Strength of SupportA CoverageA+ Formula Quality
Vitamin K · 100 mcgVitamin D · 125 mcg

The formula directly targets mineral structure, absorption, and remodeling with multiple bone-specific actives. Hydroxyapatite calcium, vitamin D, vitamin K, magnesium, and boron have strong complementary skeletal rationale.

The formula provides useful amounts across calcium, magnesium, vitamin D, K2, boron, and phosphorus. The formula covers mineral structure, absorption, remodeling, and trace-mineral support.

Study evidence
Vitamin D Supportive 202 studies
Vitamin K Supportive 78 studies
Heart Health
Heart Health
Impact
Highest effect
B+ Goal FitA+ Strength of SupportC+ CoverageA+ Formula Quality
Vitamin K · 100 mcgVitamin D · 125 mcg

Vitamin K2 as MK-7 provides a targeted 100 mcg amount for calcium regulation and arterial health. Vitamin D3 complements K2 by supporting calcium handling, although the D3 amount is high for routine use without checking total intake.

Softgel delivery suits these fat-soluble vitamins. Vitamin K can oppose warfarin-type anticoagulants, so intake should remain consistent under prescriber guidance.

Study evidence
Vitamin D Mixed 164 studies
Vitamin K Mixed 62 studies
General Health
General Health
Impact
Highest effect
A Goal FitB+ Strength of SupportB CoverageA+ Formula Quality
Vitamin D · 125 mcgVitamin K · 100 mcg

Vitamin D3 and K2 address complementary parts of bone, immune, and calcium metabolism support. MK-7 is provided in a preferred daily amount and the liquid softgel suits fat-soluble nutrients.

The vitamin D3 amount is concentrated and may be unnecessary for people who already have adequate vitamin D status. Vitamin K can disrupt stable warfarin dosing, so users of vitamin K antagonist medicines need prescriber guidance before changing intake.

Study evidence
Vitamin D Supportive 115 studies
Vitamin K Supportive 34 studies
Cardiovascular Support
Cardiovascular Support
Impact
Highest effect
B+ Goal FitA- Strength of SupportC+ CoverageA Formula Quality
Vitamin K · 100 mcgVitamin D · 125 mcg

MK-7 and vitamin D3 provide a focused combination for calcium regulation and vascular integrity. The 100 mcg K2 amount is meaningful, and the liquid softgel supports delivery of both fat-soluble vitamins.

The supplied ingredient data list vitamin D twice at the same amount, creating some label ambiguity, while the 125 mcg dose is high for routine maintenance. MK-7 can oppose warfarin-type anticoagulants, so stable intake and prescriber-directed anticoagulant management are necessary.

Study evidence
Vitamin D Mixed 170 studies
Vitamin K Supportive 40 studies
Anti-Aging
Anti-Aging
Impact
Highest effect
B+ Goal FitA Strength of SupportC CoverageA Formula Quality
Vitamin K · 100 mcgVitamin D · 125 mcg

Vitamin D3 and MK-7 complement one another in bone maintenance and calcium handling, supporting important aspects of aging. The liquid softgel delivers a full MK-7 serving in a format suited to fat-soluble vitamins.

The active forms and amounts are clear, though the MK-7 source and isomer purity are not identified. The concentrated vitamin D3 may be excessive for users with adequate status, and MK-7 can interfere with stable warfarin dosing.

Study evidence
Vitamin K Supportive 27 studies

Ingredients

IngredientAmount per serving
Vitamin D (Cholecalciferol, Vitamin D3)
 125 mcg
Vitamin K (Menaquinone-7)
 100 mcg
Gluten Free Adults 18–50 Vegan Vegetarian
Report overview
Vitamin K (Menaquinone-7) · 100 mcg OverallScore95
A- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value

The liquid softgel supplies MK-7 in the preferred daily range and pairs it with vitamin D3. Its delivery format is well suited to a fat-soluble vitamin, though the MK-7 source and isomer purity are not disclosed. The concentrated vitamin D3 amount may be unnecessary for some users, and vitamin K can interfere with stable warfarin dosing.

View ingredientView products
Loading alternative details
87 Performance

Vitamin K2 100 mcg

SR Sports Research
<p>The formula provides 100 mcg of Vitamin K2 (Menaquinone-7), which may be a better fit than the original’s 100 mcg of Vitamin K (Menaquinone-7), 125 mcg of Vitamin D (Cholecalciferol), and 125 mcg of Vitamin D (Vitamin D3) when its specific vitamin K form and companion nutrients are preferred. Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
86 Performance

Vitamin K2 MK-7 (Menaquinone-7) 90 mcg

Carlson
<p>The formula provides 90 mcg of Vitamin K2 (Menaquinone-7), which may be a better fit than the original’s 100 mcg of Vitamin K (Menaquinone-7), 125 mcg of Vitamin D (Cholecalciferol), and 125 mcg of Vitamin D (Vitamin D3) when its specific vitamin K form and companion nutrients are preferred. Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
87 Performance

Vitamin K2 as MK-7 100 mcg

Healthy Origins
<p>The formula provides 100 mcg of Vitamin K2 (Menaquinone-7), which may be a better fit than the original’s 100 mcg of Vitamin K (Menaquinone-7), 125 mcg of Vitamin D (Cholecalciferol), and 125 mcg of Vitamin D (Vitamin D3) when its specific vitamin K form and companion nutrients are preferred. Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
88 Budget

Vitamin K2 MK-7 100 mcg

Nutricost
<p>At a lower recurring cost, the formula provides 100 mcg of Vitamin K (Menaquinone-7), making it a practical budget alternative to the original’s 100 mcg of Vitamin K (Menaquinone-7), 125 mcg of Vitamin D (Cholecalciferol), and 125 mcg of Vitamin D (Vitamin D3). Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
87 Budget

MK-7 Vitamin K-2 100 mcg

NOW
<p>At a lower recurring cost, the formula provides 100 mcg of Vitamin K2 (Menaquinone-7), making it a practical budget alternative to the original’s 100 mcg of Vitamin K (Menaquinone-7), 125 mcg of Vitamin D (Cholecalciferol), and 125 mcg of Vitamin D (Vitamin D3). Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
85 Budget

Vitamin K2 MenaQ7 100 mcg

AN Amazing Nutrition Amazing Formulas
<p>At a lower recurring cost, the formula provides 100 mcg of Vitamin K2 (Natto), making it a practical budget alternative to the original’s 100 mcg of Vitamin K (Menaquinone-7), 125 mcg of Vitamin D (Cholecalciferol), and 125 mcg of Vitamin D (Vitamin D3). Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
86 Value

Vitamins D3 2500 IU (62.5 mcg) & K2 120 mcg

NaturesPlus
<p>The formula combines 120 mcg of Vitamin K2 (Menaquinone-7) and 62.50 mcg of Vitamin D3 (Cholecalciferol) with favorable serving value, which may offer a better quality-to-cost balance than the original’s 100 mcg of Vitamin K (Menaquinone-7), 125 mcg of Vitamin D (Cholecalciferol), and 125 mcg of Vitamin D (Vitamin D3). Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
87 Value

MK-7 Vitamin K-2 100 mcg

NOW
<p>The formula combines 100 mcg of Vitamin K-2 (Menaquinone-7) with favorable serving value, which may offer a better quality-to-cost balance than the original’s 100 mcg of Vitamin K (Menaquinone-7), 125 mcg of Vitamin D (Cholecalciferol), and 125 mcg of Vitamin D (Vitamin D3). Vitamin K may interfere with warfarin-type anticoagulants, so people using them need clinician-directed intake.</p>
86 Value

Vitamin K2 100 mcg + Vitamin D3 125 mcg

Nutricost
<p>The formula combines 100 mcg of Vitamin K (Menaquinone-7) and 125 mcg of Vitamin D (Cholecalciferol) with favorable serving value, which may offer a better quality-to-cost balance than the original’s 100 mcg of Vitamin K (Menaquinone-7), 125 mcg of Vitamin D (Cholecalciferol), and 125 mcg of Vitamin D (Vitamin D3). The high vitamin D amount warrants attention to total intake, and vitamin K may interfere with warfarin-type anticoagulants.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
    Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Randomized trial244 participantsBone Health forVitamin K
  2. Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL.
    Chou SH; Booth SL; Cook NR; Kim E; Kotler G; Fu X; Buring JE; Manson JE; LeBoff MS · JBMR plus · 2026
    Randomized trial771 participantsBone Health forVitamin K
  3. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
    Zhou M; Han S; Zhang W; Wu D · Journal of bone and mineral metabolism · 2022
    Meta-analysis6,853 participants9 studies pooledBone Health forVitamin K
  4. Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.
    Shea MK; Barger K; Booth SL; Matuszek G; Cushman M; Benjamin EJ; Kritchevsky SB; Weiner DE · The American journal of clinical nutrition · 2020
    Meta-analysis3,891 participants3 studies pooledAnti-Aging General Health forVitamin K
  5. Topical Menaquinone‑7 (Vitamin K2, MK-7) as a Mitochondrial Bioenergetic Activator for Skin Anti-Aging: Mechanistic Evidence in Skin Cells and a Randomized Split-Face/Neck Study.
    Huang H; Wei R; Xu C; Liu C; Zhao S; Li Y; Wang M · ACS omega · 2026
    Randomized trial30 participantsAnti-Aging forVitamin K
  6. Vitamin K status and cognitive function in healthy older adults.
    Presse N; Belleville S; Gaudreau P; Greenwood CE; Kergoat MJ; Morais JA; Payette H; Shatenstein B; Ferland G · Neurobiology of aging · 2014
    Cross-sectional study320 participantsAnti-Aging forVitamin K
  7. High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam.
    Machado-Fragua MD; Hoogendijk EO; Struijk EA; Rodriguez-Artalejo F; Lopez-Garcia E; Beulens JW; van Ballegooijen AJ · European journal of nutrition · 2021
    Cohort study644 participantsAnti-Aging forVitamin K
  8. Vitamin K Concentration and Cognitive Status in Elderly Patients on Anticoagulant Therapy: A Pilot Study.
    Alisi L; Cafolla C; Gentili A; Tartaglione S; Curini R; Cafolla A · Journal of aging research · 2022
    Cross-sectional study85 participantsAnti-Aging forVitamin K
  9. Pregnancy vitamin D supplementation and offspring bone mineral density in childhood follow-up of a randomized controlled trial.
    Moon RJ; D' Angelo S; Curtis EM; Ward KA; Crozier SR; Schoenmakers I; Javaid MK; Bishop NJ; Godfrey KM; Cooper C; Harvey NC; MAVIDOS Trial Group · The American journal of clinical nutrition · 2024
    Randomized trial454 participantsBone Health forVitamin D
  10. Vitamin D analogs and bone: preclinical and clinical studies with eldecalcitol.
    Matsumoto T; Takano T; Saito H; Takahashi F · BoneKEy reports · 2014
    Narrative reviewBone Health forVitamin D
  11. Efficacy of vitamin D fortified foods on bone mineral density and serum bone biomarkers: A systematic review and meta-analysis of interventional studies.
    Tangestani H; Djafarian K; Emamat H; Arabzadegan N; Shab-Bidar S · Critical reviews in food science and nutrition · 2020
    Meta-analysis1,786 participants20 studies pooledBone Health forVitamin D
  12. Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial.
    Tsujita M; Doi Y; Obi Y; Hamano T; Tomosugi T; Futamura K; Okada M; Hiramitsu T; Goto N; Isaka Y; Takeda A; Narumi S; Watarai Y · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Randomized trial193 participantsBone Health forVitamin D
  13. Vitamin D supplementation and bone health in post-menopausal women: a 24-month randomized controlled intervention with enhanced bioavailability formulations.
    Rasool N; Munir Y · European journal of clinical nutrition · 2026
    Randomized trial612 participantsBone Health forVitamin D
  14. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
    Cockayne S; Adamson J; Lanham-New S; Shearer MJ; Gilbody S; Torgerson DJ · Archives of internal medicine · 2006
    Meta-analysis13 studies pooledBone Health forVitamin K
  15. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S · Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association · 2001
    Randomized trial92 participantsBone Health forVitamin K
  16. Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
    Koitaya N; Sekiguchi M; Tousen Y; Nishide Y; Morita A; Yamauchi J; Gando Y; Miyachi M; Aoki M; Komatsu M; Watanabe F; Morishita K; Ishimi Y · Journal of bone and mineral metabolism · 2015
    Randomized trial48 participantsBone Health forVitamin K
  17. Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
    Norouzzadeh M; Rashedi MH; Mahdavi-Mazdeh G; Kosari A; Shahinfar H · Current atherosclerosis reports · 2026
    Meta-analysisCardiovascular Support Heart Health forVitamin D
  18. A Randomized Trial of Vitamin D Supplementation on Vascular Function in CKD.
    Kumar V; Yadav AK; Lal A; Kumar V; Singhal M; Billot L; Gupta KL; Banerjee D; Jha V · Journal of the American Society of Nephrology : JASN · 2017
    Randomized trial120 participantsCardiovascular Support forVitamin D
  19. Randomized, placebo-controlled, double-blind clinical trial on the contributions of vitamin D in the control of cardiovascular risk factors, depressive symptoms and suicide risk.
    Porto C; Petribu K; Barbosa N; Magalhães R; Lira C; Porto AB; Markman-Filho B; Lordsleem A; Calado E; Magalhães J; Sougey E; Silva T; Junio A; Bandeira F; Leão R · American heart journal plus : cardiology research and practice · 2025
    Randomized trial224 participantsCardiovascular Support forVitamin D
  20. Dose responses of vitamin D3 supplementation on arterial stiffness in overweight African Americans with vitamin D deficiency: A placebo controlled randomized trial.
    Raed A; Bhagatwala J; Zhu H; Pollock NK; Parikh SJ; Huang Y; Havens R; Kotak I; Guo DH; Dong Y · PloS one · 2017
    Randomized trial70 participantsCardiovascular Support forVitamin D
  21. Paricalcitol and endothelial function in chronic kidney disease trial.
    Zoccali C; Curatola G; Panuccio V; Tripepi R; Pizzini P; Versace M; Bolignano D; Cutrupi S; Politi R; Tripepi G; Ghiadoni L; Thadhani R; Mallamaci F · Hypertension (Dallas, Tex. : 1979) · 2015
    Randomized trial88 participantsCardiovascular Support Heart Health forVitamin D
  22. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
    Bellinge JW; Dalgaard F; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Sim M; Croft KD; Gislason G; Torp-Pedersen C; Tjønneland A; Overvad K; Hodgson JM; Schultz C; Bondonno NP · Journal of the American Heart Association · 2021
    Cohort study53,372 participantsCardiovascular Support Heart Health forVitamin K
  23. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
    Knapen MH; Braam LA; Drummen NE; Bekers O; Hoeks AP; Vermeer C · Thrombosis and haemostasis · 2016
    Randomized trial244 participantsCardiovascular Support Heart Health forVitamin K
  24. Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Post-Menopausal Women.
    de Vries F; Bittner R; Maresz K; Machuron F; Gåserød O; Jeanne JF; Schurgers LJ · Nutrients · 2025
    Randomized trial165 participantsCardiovascular Support forVitamin K
  25. Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
    Schultz CJ; Dalgaard F; Bellinge JW; Murray K; Sim M; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Gislason GH; Tjønneland A; Overvad K; Hodgson JM; Bondonno NP · Arteriosclerosis, thrombosis, and vascular biology · 2024
    Cohort study55,545 participantsCardiovascular Support Heart Health forVitamin K
  26. Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
    Palmer CR; Bellinge JW; Dalgaard F; Sim M; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Croft KD; Gislason G; Tjønneland A; Overvad K; Schultz C; Lewis JR; Hodgson JM; Bondonno NP · European journal of epidemiology · 2021
    Cohort study56,048 participantsCardiovascular Support Heart Health forVitamin K
  27. Vitamin D supplementation for prevention of mortality in adults.
    Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C · The Cochrane database of systematic reviews · 2014
    Meta-analysis95,286 participants159 studies pooledGeneral Health forVitamin D
  28. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial.
    Abbasnezhad A; Amani R; Hajiani E; Alavinejad P; Cheraghian B; Ghadiri A · Neurogastroenterology and motility · 2018
    Randomized trial90 participantsGeneral Health forVitamin D
  29. The impact of vitamin D administration on mortality in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials.
    Kow CS; Ramachandram DS; Hasan SS; Wong Z; Thiruchelvam K · Inflammopharmacology · 2024
    Meta-analysis2,495 participants19 studies pooledGeneral Health forVitamin D
  30. Vitamin D Status and Mortality: A Systematic Review of Observational Studies.
    Heath AK; Kim IY; Hodge AM; English DR; Muller DC · International journal of environmental research and public health · 2019
    Systematic review84 studies pooledGeneral Health forVitamin D
  31. Meta-analysis of long-term vitamin D supplementation on overall mortality.
    Zheng Y; Zhu J; Zhou M; Cui L; Yao W; Liu Y · PloS one · 2014
    Meta-analysis42 studies pooledGeneral Health forVitamin D
  32. Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patients.
    Huang Y; Zhu X; Han L; Hu H · Scientific reports · 2025
    Cohort study7,857 participantsGeneral Health forVitamin K
  33. The Effect of Topical Vitamin K1 on the Treatment of Cetuximab-Induced Skin Rashes in Metastatic Colorectal Cancer Patients.
    Roayaei M; Rezaei M; Najafizade N · Advanced biomedical research · 2024
    Randomized trial49 participantsGeneral Health forVitamin K
  34. Effect of vitamin K on improving post‑kidney transplant outcomes: a meta‑analysis.
    Sun Z; Zhu K; Liang G; Yan F; Chao S; Jia L; Niu Y · Experimental and therapeutic medicine · 2023
    Meta-analysis7 studies pooledGeneral Health forVitamin K
  35. Vitamin K1 intake is associated with lower risk for all-cause and cardiovascular disease mortality in community-dwelling older Australian women.
    Dupuy M; Radavelli-Bagatini S; Zhong L; Dalla Via J; Zhu K; Blekkenhorst LC; Bondonno NP; Linneberg A; Bellinge JW; Schultz C; Courtney W; Prince RL; Hodgson JM; Lewis JR; Sim M · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2024
    Cohort study1,436 participantsGeneral Health forVitamin K
  36. Vitamin D supplementation for cardiometabolic risk markers in pregnant women based on the gestational diabetes mellitus or obesity status : a randomized clinical trial.
    Yin WJ; Wang P; Ma SS; Tao RX; Hu HL; Jiang XM; Zhang Y; Tao FB; Zhu P · European journal of nutrition · 2024
    Randomized trial1,537 participantsHeart Health forVitamin D
  37. Vitamin D Supplementation, Serum 25(OH)D Concentrations and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis.
    Mirhosseini N; Rainsbury J; Kimball SM · Frontiers in cardiovascular medicine · 2020
    Meta-analysis81 studies pooledHeart Health forVitamin D
  38. Does vitamin D supplementation modulate metabolic risk factors of cardiovascular disease? A systematic review and meta-analysis of clinical trials.
    Abumweis S; Alqadi S; Al Tarteer A; Alrefai W; Alzoughool F; Jew S; Qudah T · Asia Pacific journal of clinical nutrition · 2026
    Meta-analysis45 studies pooledHeart Health forVitamin D
  39. The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
    Bellinge JW; Francis RJ; Lee SC; Bondonno NP; Sim M; Lewis JR; Watts GF; Schultz CJ · The American journal of clinical nutrition · 2022
    Randomized trial149 participantsHeart Health forVitamin K